Form 4: Trevena Inc. Director, Marvin Johnson, Reports Stock Option Grant

Director Marvin Johnson reports acquisition of stock options in Trevena Inc.

Summary

• On June 13, 2024, Marvin Johnson, a director of Trevena Inc. (TRVN), reported a transaction.
• Johnson acquired 13,700 stock options with an exercise price of $0.4.
• These options vest fully on the first anniversary of the grant date, contingent upon continuous service.
• Following the transaction, Johnson directly owns 13,700 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing regarding stock option grants, which is generally neutral. The grant itself can be seen as a positive sign of aligning director interests with the company's success.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting equity if the options are exercised in the future.
• The grant incentivizes the director to work towards increasing shareholder value.

Key Dates

Keywords

stock options, Form 4, director, Trevena Inc., TRVN, beneficial ownership, securities